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ABSTRACT  
A new strategy for the identification of known compounds in Streptomyces extracts that can be 
applied in the discovery of natural products is presented. The strategy incorporates screening a 
database of 5,553 natural products including 5,102 structures from Streptomyces sp. alone, using 
a high throughput LCMS data processing algorithm that utilises HRMS data and predicted LC 
retention times (tR) as filters for rapid identification of compounds in the natural product extract. 
The database named StrepDB contains for each compound, the structure, molecular formula, 
molecular mass, and LC predicted retention time. All identified compounds are annotated and 
color coded for easier visualization. It is an indirect approach to quickly assess masses (which 
are not annotated) that may potentially lead to the discovery of new or novel structures. In 
addition, a spectral database named MbcDB was generated using ACD/Spectrus DB Platform. 
MbcDB contains 665 natural products, each with structure, experimental HRESIMS, MS/MS, 
UV, and NMR spectra. StrepDB was used to screen a mutant Streptomyces albus extract that led 
to the identification and isolation of two new compounds: legonmaleimides A and B, the 
structures of which were elucidated with the aid of MbcDB and spectroscopic techniques. The 
structures were confirmed by computer assisted structure elucidation (CASE) methods using 
ACD/Structure Elucidator Suite. The developed methodology suggests a pipeline approach to the 
dereplication of extracts and discovery of novel natural products.  
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The need for increasing productivity in the discovery of new or novel drug-like compounds has 
resulted in the search for new techniques and strategies to streamline the drug discovery pipeline. 
Central to this is the rapid identification of known compounds and analogues, a process known 
as chemical dereplication1–3 enabling resources to be focused on extracts that can yield new or 
novel compounds. The most commonly employed methods involve the use of liquid 
chromatography coupled to a photodiode array detector and a high resolution mass spectrometer 
(LC-DAD-MS).4,5 The use of HRESIMS offers advantages over other methods, for example UV 
and NMR due to its high sensitivity and versatility, enabling it to produce more than one type of 
data in a single experiment such as positive, negative and fragmentation. However, determining 
molecular structures is more challenging and despite advances in MS technology, the process 
still needs NMR techniques to provide full structural information. Chemical dereplication 
methods available today use either one or both of these methods and generally fall into two main 
categories: targeted or non-targeted dereplication. Non-targeted chemical dereplication methods 
are less focused and often result in wasted time and resources due to reisolation of known 
compounds. Targeted chemical dereplication offers advantages as it allows resources to be 
utilized on isolation of new compounds or targeted isolation of known compounds for example 
with interesting biological activity.4 For example LC-DAD-TOFMS was used to successfully 
identify known fungal metabolites by comparison of UV and MS data with reference standards.6 
The use of a database containing HRMS, MS/MS and UV data was used to rapidly identify the 
presence of aflatoxins which are nuisance mycotoxins in crude fungal extracts.7 The use of 
MS/MS data to build molecular networks can identify compounds that are structurally related,8,9 
but requires MS/MS data in integrated compound databases for their identification. Current 
MS/MS libraries containing experimental MS/MS data are known to cover only a limited 
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number of natural products, estimated to be around 10%.9 The combination of LCMS and 
phylogenetic finger printing was used in the targeted discovery of cyanobacterial compounds.10 
NMR spectroscopy, despite the problem of low sensitivity is increasingly being used for 
dereplication purposes.11–13 The use of experimental LC retention time by comparing the 
retention time of an unknown with the retention time of a known standard compound is a 
commonly employed method of identifying compounds when used orthogonally with another 
data source like HRMS or MS/MS.7,14 However, it is not practical to purchase every known 
compound in the natural products database for measurement of experimental retention times 
considering the fact that there are about 250,000 of natural products15 known to date. Use of 
predicted retention times, however is a possible alternative and has been studied for metabolite 
identification.16 Prediction of retention times follows the concept of quantitative structure 
retention relationship (QSRR) which is based on the physicochemical nature of the analyte-
column interactions that determine retention.17 It has been successfully applied to HPLC for 
identification of specific classes of compounds such as peptides,18 steroids,19 and lipids.20 
Application in chemically diverse group such as organic synthetic compounds has been carried 
out successfully,21 but has yet to be applied in the identification of natural products. The huge 
diversity of structures in natural products is believed to be a challenge for any retention time 
prediction model,16 but, it has the potential to work successfully as an extra filter when used with 
HRMS in a high throughput screening strategy to  rapidly improve the identification of known 
natural products which is often one of the major bottle-necks22 in drug discovery. 
  
The goal of this study was to identify new natural products easily from Streptomyces sp. through 
rapid screening of known compounds held in a Streptomyces natural products database, StreDB. 
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To facilitate this requires first of all the construction of the database, StrepDB to contain the 
necessary information such as structures, molecular formulas, molecular masses, and predicted 
LC-retention times for all compounds. And, secondly to determine and optimize the accuracy of 
the method in its ability to identify known standard compounds in an extract. Complimentary to 
this was the construction of a spectral natural product database, MbcDB which contains NMR, 
LCMS, MS/MS, and UV data of 665 natural products. Spectral databases are crucial for 
identifying known compounds or providing spectral information for the elucidation of new 
structures. To test this new approach we build two databases (StrepDB and MbcDB), and looked 
at the screening, isolation and characterization of new pyrrolidine alkaloids related to the 
legonmycins and the legonindolizidines23 in a mutant Streptomyces extract. 
 
RESULTS AND DISCUSSION 
StrepDB. The Antimarin database24 (version 2011) holds 15,831 unique masses and 35,850 
molecular structures. The bacterial genus Streptomyces alone contributes about 6,845 structures to 
this database. These Streptomyces derived structures were imported to ACD/ChemSketch25 and 
checked for structural irregularities using the ‘clean structure’ option available in ChemSketch. 
After removal of duplicated structures the remaining MDL MOL files (5,098 or 74.5% of the 
original structures) were imported to IntelliXtract (an add-in software of ACD/MS Workbook 
Suite)25 to generate StrepDB. StrepDB holds 5,100 compounds from Streptomyces and 453 
compounds from other sources giving a total of 5,553 compounds with structures, exact masses, 
molecular formulae, and predicted LC retention times (Table 1, Figures S3-S8). Two known 
compounds (jasplakinolide and antibiotic A-23187) were analysed by LCMS and the HRMS data 
used to optimize the data preprocessing settings (S43). The green colour-coded output files 
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shown in Figures S1 and S2 indicated that the accuracy target of 5 ppm has been observed for 
both compounds. Optimization of preprocessing settings is important as it affects the peak-
picking, alignment and data accuracy of the applied algorithm,26,27 particularly in complex 
biological samples. To determine the impact of retention time, and retention time window on the 
number of identified peaks, a crude sample of Streptomyces sp. MA3723 was analysed by LCMS, 
and the data processed by IntelliXtract and screened by StrepDB using two different settings for 
retention time. The first was keeping both the retention time (tR), and retention time window (tR 
window) unfilled (S46). The second was using the predicted values for tR, but used seven 
different settings for tR window: no value, 0.0, 1.5, 2.0, 2.5, 3.0, and 4.0 minutes (S46 – S51, S3). 
The results (even though the number of sample is limited) showed an inverse correlation (R2 = 
0.97) between the retention time window used and the number of annotated compounds removed 
(S52-S59), considered as false hits. For example, a retention time window of 1.5 minutes 
removed up to 90% of hits when HRMS is used alone indicating the importance of retention time 
(and retention time window) as an additional filter in compound identification. To demonstrate 
the accuracy of the strategy a known component of Streptomyces sp. MA37, legonmycin A23 was 
processed where the predicted retention time, structure, and other information were inputted into 
StrepDB and the LCMS data analysed as before. This time the mass 253.1555 that had 
previously been ‘unlabeled’ was annotated correctly as legonmycin A (Figure S60). The 
difference between experimental and predicted retention times of legonmycin A was 2.6 minutes, 
well within the 4.0 minute retention time window set in StrepDB. 
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Table 1 StrepDB contains 5,553 compounds including 5,102 structures from Streptomyces 
with names, molecular formulae, high resolution monoisotopic masses, and calculated LC-
retention times. More compounds can be added either directly to the table or via XML files. 
 
MbcDB. This database holds spectral data for 665 natural products from marine and 
terrestrial sources representing several classes of natural products such as peptides (30), alkaloids 
(120), terpenes (300) and others (215). A library of 502 of compounds was obtained from Enzo 
Life Sciences UK28 while the rest (163) came from our in-house compound collections. The 
database holds information such as compound structure, references, text files such as SMILES, 
and InChIKey, HRESIMS, LRMS/MS, 1H NMR and UV spectra for all compounds. HRESIMS 
and MS/MS data are in positive mode with some in the negative mode (<10%). For a selection of 
compounds (<10%) there are 13C and 2D NMR data such as COSY, HSQC and HMBC (Figure 
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S9). Since all the spectral data are stored as raw data files these can be reprocessed if required 
(Figures 1, S10-S13). 
 
Figure 1.  MbcDB contains 665 compounds with spectral data such HRMS, LRMS/MS, UV 
and 1H NMR. The database is searchable based on compound name, molecular formula, exact 
mass, structure, and substructure. Spectra of unknown compounds such as UV, 1D & 2D NMR, 
MS and MS/MS can be searched for similarities with spectra held within MbcDB (e.g. Figures 
S19, S28, S44, S45). 
Calculation of LC Retention Times. The LC-retention times of compounds in StrepDB were 
calculated using ACD/ChromGenius25 The software uses physicochemical parameters like logP, 
logD, molecular weight (MW), molecular volume (MV), molar refractivity (MR), polar surface 
area (PSA), H-acceptors (NA), and H-donors (ND) to create a knowledge base using a set of 
‘training’ compounds that had been measured previously.25 To create the knowledge base, 417 
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natural products from MbcDB with structures, monoisotopic masses, and LCMS data (Figures 
S14, S15) were downloaded to ChromGenius. Calculations were performed for the method used 
(solvents, pH, temperature, column type, column size, and experimental LC-retention time) to 
build the prediction model. Retention times were predicted for each compound using the 10% 
most similar compounds in the knowledge base obtained by a Dice coefficient similarity 
search.29 An overall correlation value (R2= 0.75) between the experimental and predicted 
retention times of the 417 standard compounds was obtained (Figure 2). Analysis of the data 
showed that 76% of the standard (training) compounds had retention time deviation 
(experimental minus predicted) between 0.0-2.0 minutes, 93% between 0.0-4.0, and the rest (7%) 
between 4.2-10.3 minutes (Table S61). The model was then used to calculate the retention times 
of the 5,553 compounds held in StrepDB (Table 1).   
 
Figure 2. Correlation between predicted and experimental LC retention times, n = 417. 
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Figure 3. The calculated LC elution profile of dynactin (structure shown), correlation between 
predicted and experimental LC retention times of the 26 compounds used in the calculation are 
shown. A similarity coefficient (Sim Coeff) of 0.87 was obtained. A similarity coefficient of 1.0 
indicates a perfect match between calculated and experimental retention times. 
Dereplication using StrepDB. The Streptomyces strain used in this study was obtained from 
a soil sample from the University of Ghana, Africa and the subsequent construction of the 
legonmycin gene cluster, in-frame deletion and expression of the mutant strain have been 
described previously.23 The crude sample of Streptomyces albus, ΔlgnC was fractionated into 
four fractions: water-butanol, water-methanol, dichloromethane, and hexane based on polarity 
using a modified Kupchan method.30,31 The four fractions were subjected to LCMS analysis, but 
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only the water-butanol fraction was prioritized over the other three for compound isolation 
workup based on the amount (dried weight) of fraction and relative intensity of the ions to the 
quality control sample (reserpine). Data processing of this fraction and subsequent screening of 
StrepDB by IntelliXtract using a retention time window of 4.0 ( 2.0) minutes resulted in 71 
masses between 200-500 Da, of which four masses were annotated as matching 10 compounds in 
StrepDB (Table S41). The structures of these compounds are easily displayed by switching to 
‘Table of Components’ view (Figure S42). The data suggested that the remaining 67 masses 
(94% of the total masses) were not in StrepDB, and were potentially new compounds. A UV 
profile filter was then applied manually to target only the compounds related to the 
legonindolizidines,23 resulting in eleven masses with the expected UV profile (Table S16, Figure 
S17). Inspection of the data indicated that one of the compounds of interest had been identified 
as legonindolizidine A (Figure S42). Legonindolizidines23 A (3) and B (4) have previously been 
isolated from this strain, and their structures characterised based on 1H NMR, MS and MS/MS 
data.23 Legonindolizidine B was also identified (results not shown), after applying a retention 
time window of 6.0 minutes. Out of the nine unidentified masses of interest (based on UV 
profile), two were isolated, purified, and the structures elucidated as new legonmaleimides. The 
yield of the remaining seven compounds after HPLC purification were far too low for 
measurement of 1D and 2D NMR data, and hence their structures remained to be determined.  
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Figure 4. IntelliXtract output file of the water-butanol fraction showing the presence of adenine-
9-beta-D-arabinofuranoside. The total ion chromatogram (top) is overlaid with the extracted ion 
chromatogram (bottom) for visualization of peak retention times. All extracted ions can be 
visualized as either a mass list (Table S41) or as a table of component containing structures 
(Table S42). The dark-green in the MS/Match column has indicated an excellent match with the 
compound adenine 9-beta-D-arabinofuranoside in StrepDB. 
Isolation and Structure Determination. The water-butanol fraction was purified by a C18 
HPLC column using a water-methanol gradient to afford the new compounds legonmaleimides A 
(1) and B (2), and the known compounds legonindolizidines23A (3) and B (4).  
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HRESIMS of legonmaleimide A (1) gave a molecular formula of C14H21O5N2 requiring 6 
degrees of unsaturation (Figure S18). A 1H NMR spectrum search of MbcDB  suggested proton 
signal similarities to the known legonindolizidines (Figure S19).23 Interpretation of 1H, edited 
HSQC, and HMBC NMR data (Figures S20, S21, S23) indicated the presence of four 
methylenes (C 44.7, 37.6, 34.9, 25.4 ppm), one methine (C 25.9 ppm), two sp2 (C 132.9, 122.2 
ppm), three amides (C 172.2, 172.1, 168.0 ppm), and one carboxylic acid group (C 180.0 ppm) 
suggesting the presence of one ring in the structure of 1. The full structure was assigned by the 
interpretation of 1D and 2D NMR data in particular COSY (Figure S22), HMBC correlations 
(Table 2, Figure 5), and by comparison of NMR data with those of farinomalien, a maleimide-
bearing compound from the entomopathogenic fungus Paecilomyces farinosus.32 The COSY 
spectrum indicated two fragments: H5-H6-H7 and H10-H11-H12/H13. HMBC correlations from 
H14 to C2, C3, C4 and from H5 to C1 and C2 established the maleimide core and the butanoic 
acid group suggesting the bonding of C5 to the maleimide nitrogen. 13C chemical shifts suggest 
that the 3-methylbutanamide unit was linked to the maleimide core at C2. Examples of 
compounds with the 3-methylbutanamide have previously been isolated from this bacterial 
strain.23  
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Figure 5. COSY and HMBC correlations of 1 and 2.  
Legonmaleimide B (2) showed a formula of C14H23O5N2 based on HRESIMS and requiring 5 
degrees of unsaturation (Figure S27). A 1H NMR spectrum search of MbcDB suggested 
similarities in proton profile to the known legonindolizidines (Figure S28).23 Interpretation of 1D 
and 2D NMR data (Figures S29-S31) suggested that compound 2 had lost the double bond 
between C2 and C3. 2D COSY and HMBC correlations (Figures S32, S33) support the proposed 
structure shown in Figure 5. The absolute stereochemistries of legonmaleimide (2) at positions 
C2 and C3 have not been determined. The relative stereochemistry, however, was determined by 
a 2D ROESY NMR experiment that showed a strong correlation between H2 to H3 indicating a 
cis-configuration (Figures S34, S35). 
Additional evidence for the two structures were provided by MS fragmentation data (Figures 
S26, S36), and by Computer Assisted Structure Elucidation (CASE) using ACD/Structure 
Elucidator Suite (version 2015.2.5).25 1D NMR (1H), and 2D NMR data including HSQC, 
COSY, ROESY and HMBC plus the molecular formula were entered into ACD/Structure 
Elucidator and all possible structures calculated (Figures S37, S40) in Fuzzy Structure 
Generation (FSG) mode to detect and resolved non-standard correlations in COSY and HMBC 
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NMR data.15,33,34 Calculations for compound 1 produced 77 possible structures 
 
Table 2. 1H, 13C, 1H-1H COSY and 1H-13C HMBC NMR data of compounds 1 and 2 at 600/150 
MHz in CD3OD 
                                                   1                                                                                                                2                
pos. C , type H (J in Hz) COSY 1H-1H aHMBC pos. C ,  type H (J in Hz)  COSY 1H-1H aHMBC 
1 168.0, C       1 176.1, C      
2 132.9, C       2 51.5, CH 4.68, d, 8.8  3   
3 122.2, C       3 38.3, CH 3.08, m  2, 14  4  
4 172.1, C       4 179.8, C      
5 37.6, CH2 3.50, t, 7.0  6  1, 4 5 37.9, CH2 3.60, t, 6.8  6  1, 4 
6 25.4, CH2 1.83, m 5, 7  8 6 22.7, CH2 1.90, m  5, 7 8 
7 34.9, CH2 2.12, overlap 6  6 7 30.8, CH2 2.08, t, 7.2  6  6 
8 180.0, C       8 175.2, C      
9 172.2, C       9 174.9, C      
10 44.7, CH2 
2.30, dd, 7.2, 
7.2 11 
 11, 12, 
13 10 44.4, CH2 
2.14, dd, 6.7, 
7.1 11  11 
11 25.9, CH 2.10, m 10, 12, 13 
 10, 12, 
13 11 26.1, CH 2.08, m 10, 13, 14  10, 12, 13 
12 21.3, CH3 0.98, d, 6.7  11 11 12 21.5, CH3 0.99, d, 6.5  11  11 
13 21.3, CH3 0.98, d, 6.7  11 11 13 21.5, CH3 0.98, d, 6.5  11  11 
14 9.0, CH3 1.97, s   4 14 9.8, CH3 1.14, d, 7.8  3  4 
 
aHMBC correlations optimized for 8.0 Hz are from proton(s) stated to the indicated carbon. 
 
which were then ranked according to the differences between the experimental and calculated 
13C data.35 The low chemical shift deviations of the HOSE-code (dA),36 incremental Method (dI),37 
and Artificial Neural Networks (dN)37 suggested that the proposed structure is correct. The top 25 
candidates are shown in Figure S38 where the proposed candidate was placed at the number 1 
position. A similar calculation performed for compound 2 yielded 92 possible structures. The top 
25 candidates are shown in Figure S39 where the proposed structure for 2 was placed at the 
number 1 position. 
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Plausible biogenetic pathway. Compound 1 is likely to be derived from the biosynthetic 
intermediate legonindolizidine A23 (3) through hydroxylation at C5, followed by ring 
rearrangement to generate a reactive aldehyde species 5, which is then oxidized to the 
corresponding carboxylic acid 1. Compound 1 is then reduced into 2 (Figure 10). 
 
 
 
Figure 10. Proposed biosynthetic pathway of compounds 1 and 2. 
 
Compound 1 was tested against the human melanoma cell line A2058 and was found to be 
inactive (100% cell survival rate at 250 µM). Compound 2 has not been tested in any biological 
assay. 
 
EXPERIMENTAL SECTION 
General Experimental Procedures. NMR data, both 1D and 2D were recorded on a Bruker 
AVANCE III HD Prodigy TCI Cryoprobe at 600 and 150 MHz for 1H and 13C respectively. This 
instrument was optimized for 1H observation with pulsing/decoupling of 13C and 15N with 2H 
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lock channels equipped with shielded z-gradients and cooled preamplifiers for 1H and 13C.  The 
1H and 13C chemical shifts were referenced to the solvent signals (δH 3.31 and δC 49.00 in 
CD3OD). High resolution mass spectrometry data were measured using a ThermoScientific 
LTQXL-Discovery Orbitrap coupled to an Accela UPLC-DAD system. The following conditions 
were used for mass spectrometric analysis: capillary voltage 45 V, capillary temperature 320 °C, 
auxiliary gas flow rate 10 -20 arbitrary units, sheath gas flow rate 40-50 arbitrary units, spray 
voltage 4.5 kV, mass range 100-2000 amu (maximum resolution 30,000). Optical rotation 
measurements were recorded using a Bellingham & Stanley, Model ADP410 Polarimeter at 589 
nm. Semi-preparative HPLC purifications were performed using an ACE 5 C18, 250 x 100 mm 
column connected to an Agilent 1100 HPLC system consisting of a binary pump, degasser, 
photodiode array (DAD) and a preparative fraction collector. This system was also used to 
record the UV profile for measurement of the molar extinction coefficient (ɛ). IR was measured 
using a Perkin Elmer FT-IR (UATR Two) spectrometer. All solvents were of HPLC grade. 
General Procedure for HPLC Analysis. Analysis by LCMS was performed on a C18 
(Agilent Poroshell 120, EC C18, 2.7 µm, 2.1 x 100 mm) column. The gradient was from 100% 
water (0.1% formic acid) to 100% acetonitrile (0.1% Formic acid) in 25 minutes and kept at this 
solvent for another 5 minutes before equilibration with the starting solvent for another 5 minutes. 
The flow rate was 0.4 mL/min, and column temperature 25 C. For the determination of the 
molar absorptivity an ACE 5 C4 (250 x 10 mm) column was used with an HPLC gradient starting 
from 5% MeOH (in water) to 100% MeOH in 10 minutes and kept at that solvent for another 10 
minutes, with a flow rate of 2.0 mL/min. For compound 1, 30 L of 0.1 mg/mL was injected to 
the column. For compound 2, 10 L of 1.4 mg/mL was used. 
 19 
StrepDB. Compound structures were copied to ACD/ChemSketch (version 2015.2.5) from 
AntiMarin24 and then converted to MDL MOL files. These were then imported into the Ion 
Presence List in IntelliXtract within ACD/MS Workbook Suite (version 2015.2.5) and saved as 
an XML file. Other information like compound names, LC retention time, retention time window 
and MS delta were either added directly to the table or via Microsoft Excel (version 2010) which 
were then reconverted to XML format before loading to MS Workbook Suite. An LC retention 
time window of 4 ( 2) minutes was added to accommodate variations in experimental retention 
time.  
LCMS data (RAW file format) were loaded to ACD/MS Work Book Suite via ACD/Spectrus 
and processed using optimized preprocessing settings using the IntelliXtract algorithm (S43). 
The m/z range was set between 200-500 Da, and LC-retention time from 2-35 minutes. The mass 
accuracy value was set as 0.5 Da; the mass value for HRMS data processing approach was set as 
 0.005 Da; mass accuracy for peak labelling 0.005 Da, and mass accuracy for structure search 
set as 0.0005 Da. Similar settings were used for the IntelliTarget algorithm (within ACD/MS 
Workbook Suite); Additional settings for IntelliTarget: Target analysis mass accuracy for MC 
generation 0.0003 Da; type of mass: peak top; mass accuracy for assignment: 0.0003 Da; FFQ 
threshold set as zero. 
MbcDB. NMR data (FID) from Varian/Agilent and Bruker were processed by ACD/NMR 
Workbook Suite, solvent referenced, extracted as single spectrum and loaded to Spectrus DB (in 
update mode) via the ‘DB update key’ within ACD/Spectrus Processor. Compound structures 
and associated information were loaded via ChemSketch. MS data were loaded via MS 
Workbook Suite, UV profile (derived from HPLC or LCMS) were loaded via the ACD/Optic 
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Workbook or ACD/MS Workbook Suite. MbcDB was saved as CryptoForge Document (CFD) 
file format. 
LC-Retention Time Calculation. Compounds (n = 417) with experimental LC-retention 
times were downloaded from the MbcDB and converted to a SDF file. These values were 
imported into ACD/ChromGenius (version 2015)25 to create a knowledge base for the given 
chromatographic method. ACD/ChromGenius created a prediction equation for each compound 
by relating retention time to key predicted physicochemical parameters. The prediction accuracy 
of the knowledge base was estimated using a leave one out approach for each compound.38 This 
knowledge base was then used to calculate the retention times of the compounds in StrepDB. 
Retention times were predicted using the 10% most similar compounds in the knowledge base 
obtained by a Dice coefficient similarity search.29 
Microbiology. The Streptomyces albus::minimal cassette ΔlgnC has been previous studied in 
which the key gene lgnC in the minimal cassette of the lgn gene cluster, responsible for the 
biosynthesis of the bacterial pyrrolizidine alkaloids, legonmycins A and B was genetically 
inactivated.23 The Streptomyces albus mutant was cultured on MS medium (mannitol 20g/L, 
soybean meal 20g/L, agar 20g/L, pH 7.2) for spore formation. For fermentation, Streptomyces 
albus was cultured on ISP2 medium. Modified ISP4 medium [10 g/L soluble starch, 2 g/L 
(NH4)2SO4, 1 g/L K2HPO4, 1 g/L MgSO4·7H2O, 1 g/L NaCl, 1 g/L tryptone, 0.5 g/L yeast 
extract, 1 g/L peptone, trace element solution (1 mL/L), pH 7.2 before sterilization] containing 
the final concentration of 30 mM Mg2+ was used for conjugation of Streptomyces albus. 
 
 21 
Isolation of the Legonmaleimides. The methanol extract of Streptomyces albus::minimal 
cassette ΔlgnC culture was dried and partitioned into four fractions: water-butanol, water-
methanol, dichloromethane and hexane according to polarity.30,31 The water-butanol fraction was 
prioritised over the others and dereplicated using StrepDB based on sample dried weight, and 
compounds of interest based on HRMS and UV profile (Table S16, Figure S17). Final 
purification was performed by reversed phase HPLC using water and methanol as solvents. The 
gradient started from 95% Water to 50% MeOH in 20 minutes and then reached 100% MeOH in 
another 10 minutes before equilibration for a further 5 minutes in the starting solvents to yield 
legonmaleimide A (2.0 mg) and legonmaleimide B (1.5 mg). 
 
Legonmaleimide A (1) 1H and 13C NMR data (CD3OD, 600 and 150 MHz, respectively), see 
Table 2; HRESIMS 297.1447 [M+H]+ Δ 0.1 ppm calculated for C14H21O5N2; UV (MeOH) max 
(log ε) 244 (3.96), 340 (3.04) nm; IR (MeOH, cm-1) : 3329, 2957, 1702, 157, 1076, 626. 
 
Legonmaleimide B (2) 1H and 13C NMR data (CD3OD, 600 and 150 MHz, respectively), see 
Table 2; HRESIMS m/z 299.1603 [M+H]+ Δ 0.7 ppm from calculated for C14H23O5N2. UV 
(MeOH) max (log ε) 210 (2.94) nm; [α]17.5D +90.9 (c 3.7 MeOH). 
  
ASSOCIATED CONTENT 
Supporting Information 
1H NMR, COSY, ROESY, HSQC, HMBC, HRESIMS, ES+ fragmentation, CASE data for 
compounds 1 and 2. StrepDB, and MbcDB components. This material is available free of charge 
via the Internet at http://pubs.acs.org. 
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